Discover
SBRA
Sabra Health Care REIT, Inc.
19.68
2 x 14.05
2 x 25.34
bid
ask
+
0.17
0.87%
2 @ 04:00 PM
19.67 -0.01 (0.05%)
| Ytd | 3.91% | |
| 1y | 7.54% |
19.59
day range
19.77
17.17
52 week range
21.28
| Open | 19.63 | Prev Close | 19.51 | Low | 19.59 | High | 19.77 | Mkt Cap | 4.96B |
| Vol | 3.51M | Avg Vol | 2.70M | EPS | 0.63 | P/E | 31.24 | Forward P/E | 26.48 |
| Beta | 0.63 | Short Ratio | 9.41 | Inst. Own | 108.08% | Dividend | 1.20 | Div Yield | 6.15 |
| Ex Div Date | 05-15 | Earning | 04-29 | 50-d Avg | 19.74 | 200-d Avg | 19.31 | 1yr Est | 22.15 |
| Income Statement | |||
| Total Revenue | 221.75M | ||
| Revenues (USD) | 221.75M | ||
| Gross Profit | 221.75M | ||
| Operating Expenses | 154.07M | ||
| Selling, General and Administrative Expense | 14.86M | ||
| Operating Income | 67.68M | ||
| Interest Expense | 28.41M | ||
| Income Tax Expense | 526.00K | ||
| Net Income | 40.88M | ||
| Net Income Common Stock | 40.88M | ||
| Net Income Common Stock (USD) | 40.88M | ||
| Consolidated Income | 40.81M | ||
| Net Income to Non-Controlling Interests | -67.00K | ||
| Earnings per Basic Share | 0.16 | ||
| Earnings per Basic Share (USD) | 0.16 | ||
| Earnings per Diluted Share | 0.16 | ||
| Dividends per Basic Common Share | 0.30 | ||
| Earning Before Interest & Taxes (EBIT) | 69.82M | ||
| Earning Before Interest & Taxes (USD) | 69.82M | ||
| Weighted Average Shares | 252.14M | ||
| Weighted Average Shares Diluted | 255.97M | ||
| Balance Sheet | |||
| Cash and Equivalents | 123.45M | ||
| Cash and Equivalents (USD) | 123.45M | ||
| Investments | 549.45M | ||
| Trade and Non-Trade Receivables | 148.09M | ||
| Property, Plant & Equipment Net | 4.70B | ||
| Total Assets | 5.59B | ||
| Total Debt | 2.67B | ||
| Total Liabilities | 2.80B | ||
| Accumulated Retained Earnings (Deficit) | -2.05B | ||
| Accumulated Other Comprehensive Income | 691.00K | ||
| Shareholders Equity | 2.79B | ||
| Shareholders Equity (USD) | 2.79B | ||
| Total Debt (USD) | 2.67B | ||
| Goodwill and Intangible Assets | 67.41M | ||
| Trade and Non-Trade Payables | 117.95M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 53.13M | ||
| Net Cash Flow from Financing | 52.10M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 45.37M | ||
| Capital Expenditure | -107.95M | ||
| Issuance (Purchase) of Equity Shares | -8.25M | ||
| Issuance (Repayment) of Debt Securities | 137.18M | ||
| Payment of Dividends & Other Cash Distributions | -75.66M | ||
| Net Cash Flow from Investing | -105.09M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.76M | ||
| Net Cash Flow from Operations | 98.36M | ||
| Effect of Exchange Rate Changes on Cash | -60.00K | ||
| Share Based Compensation | 3.10M | ||